Patents
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
07/2013
07/18/2013WO2013105061A1 Fused dihydropyrido [2,3 -b] pyrazines as ip receptor agonists for the treatment of pulmonary arterial hypertension (pah) and related disorders
07/18/2013WO2013105058A1 7,8- dihydropyrido [3, 4 - b] pyrazines as ip receptor agonists for the treatment of pulmonary arterial hypertension (pah) and related disorders
07/18/2013WO2013104597A1 Substituted triazine derivatives and use thereof as stimulators of soluble guanylate cyclase
07/18/2013WO2013104591A1 Heterocyclic derivatives as trace amine associated receptors (taars)
07/18/2013WO2013104573A1 Pyridazine amide compounds and their use as syk inhibitors
07/18/2013WO2013070117A3 Fluorine-containing 5-[2-(pyrid-3-yl)-ethyl]-2,3,4-tetrahydro-1н-pyrido[4,3-b]indoles as agents for reducing uncontrolled protein aggregation
07/18/2013WO2013048949A3 Selective nr2b antagonists
07/18/2013US20130184463 Compounds acting at multiple prostaglandin receptors giving a general anti-inflammatory response
07/18/2013US20130184307 Substituted tricyclic acid derivatives as s1p1 receptor agonists useful in the treatment of autoimmune and inflammatory disorders
07/18/2013US20130184306 Pyrido[3,4-b]indoles and methods of use
07/18/2013US20130184304 Pyrido[4,3-b]indoles and methods of use
07/18/2013US20130184303 Pyrido[4,3-b]indoles and methods of use
07/18/2013US20130184301 Methods of Treating Post-Traumatic Stress Disorder Using Pro-Neurogenic Compounds
07/18/2013US20130184300 Methods of Treating Traumatic Brain Injury Using Pro-Neurogenic Compounds
07/18/2013US20130184297 Quinazoline derivatives substituted by aniline, preparation method and use thereof
07/18/2013US20130184294 Pyrimidones for Treatment of Potassium Channel Related Diseases
07/18/2013US20130184289 3-(imidazolyl)-pyrazolo[3,4-b]pyridines
07/18/2013US20130184284 Diaminocyclohexane compounds and uses thereof
07/18/2013US20130184277 Adamantyl diamide derivatives and uses of same
07/18/2013US20130184271 Methods for Treating Parkinson's Disease Using Pro-Neurogenic Compounds
07/18/2013US20130184269 Bridged heterocyclic compounds and methods of use
07/18/2013US20130184256 New substituted glycinamides, process for their manufacture and use thereof as medicaments
07/18/2013US20130184255 Fused heterocyclic compounds as ion channel modulators
07/18/2013US20130184254 Azaindazole compounds
07/18/2013US20130184253 Tetrahydropyrido-pyridine and tetrahydropyrido-pyrimidine compounds and use thereof as c5a receptor modulators
07/18/2013US20130184252 Dihydropyrrolonaphthyridinone compounds as inhibitors of jak
07/18/2013US20130184240 Hetero ring-fused imidazole derivative having ampk activating effect
07/18/2013US20130184155 Herbicidal Benzoxazinones
07/18/2013US20130180590 Phenanthroline compound, electron transport material obtained from said compound, and organic thin-film solar cell comprising said compound
07/18/2013CA2860826A1 Substituted triazine derivatives and use thereof as stimulators of soluble guanylate cyclase
07/18/2013CA2856204A1 Heterocyclic derivatives as trace amine associated receptors (taars)
07/17/2013EP2615090A1 Nitrogen-containing fused heterocyclic compounds and their use as beta amyloid production inhibitors
07/17/2013EP2615089A1 Pyrazoloquinoline compound
07/17/2013EP2615087A2 Phenylalanine derivatives
07/17/2013EP2614062A1 Imidazo [1, 2]pyridazin compounds and compositions as trk inhibitors
07/17/2013EP2614061A1 Quinoline and quinoxaline derivatives as kinase inhibitors
07/17/2013CN103209981A Hetero ring-fused imidazole derivative having ampk activating effect
07/17/2013CN103209960A Sulfonamide compounds useful as CYP17 inhibitors
07/17/2013CN103204853A Micrometer wire made from perylene bisimide derivatives and application of micrometer wire
07/17/2013CN103204852A Heteroaryl amide analogues as P2X7 antagonists
07/17/2013CN103204851A Benzamide derivative containing fused heterocyclic group and therapeutic use thereof
07/17/2013CN103204816A Piperazinyl pyrimidine derivative, and preparation method and application thereof
07/17/2013CN103204813A Condensed imidazole derivatives as TRPV3 antagonist
07/17/2013CN103204805A Key intermediates of AB-type PBZ monomer, and preparation method thereof
07/17/2013CN101743246B 2-oxo-2- (2-phenyl-5,6,7,8-tetrahydro-indolizin-3-yl) -acetamide derivatives and related compounds as antifungal agents
07/17/2013CN101641339B Compounds for the prevention and treatment of cardiovascular diseases
07/17/2013CN101622242B Bicyclic derivatives as CETP inhibitors
07/17/2013CN101248050B Organic compounds
07/17/2013CN101203495B Benzocycloheptapyridines as inhibitors of the receptor tyrosine kinase MET
07/16/2013US8487102 Pyrrazolopyridine compounds as dual NK1/NK3 receptor antagonists
07/16/2013US8486979 Analgesics; central nervous system disorders; attentiondeficit disorders;cognition activators; bipolar disorders; Alzheimer's disease; Down's syndrome; brain disorders
07/16/2013US8486969 Therapeutic compounds
07/16/2013US8486966 9-(pyrazol-3-yl)-9H-purine-2-amine and 3-(pyrazol-3-yl) -3H-imidazo[4,5-B] pyridin-5-amine derivatives and their use for the treatment of cancer
07/16/2013US8486964 Fused pyrrolidino-cyclopropane derivatives as selective 11-beta-hydroxysteroid dehydrogenase type 1 inhibitors
07/16/2013US8486961 Pyrrolo[4,3,2-de]quinolin-8-amine compounds and methods of their preparation and use
07/16/2013US8486957 Chemotherapeutic for inducing an MSH2-dependent apoptotic pathway
07/16/2013US8486952 Compounds for the reduction of β-amyloid production
07/16/2013US8486936 Antagonist of smoothened
07/11/2013WO2013102992A1 Material for organic electroluminescence element and element using same
07/11/2013WO2013102655A1 4,4-disubstituted-1,4-dihydropyrimidines and the use thereof as medicaments for the treatment of hepatitis b
07/11/2013WO2013102242A1 Heterocyclic compounds and methods for their use
07/11/2013US20130178631 Novel alkynyl derivatives as modulators of metabotropic glutamate receptors
07/11/2013US20130178629 SYNTHESIS OF 4H-BENZO[D]PYRROLO[1,2-A]THIAZOLES AND INDOLIZINO[6,7-b]INDOLE DERIVATIVES AND THEIR USE AS ANTITUMOR THERAPEUTIC AGENTS
07/11/2013US20130178497 Fused triazoles for the treatment or prophylaxis of mild cognitive impairment
07/11/2013US20130178496 Modulators of cystic fibrosis transmembrane conductance regulator
07/11/2013US20130178488 Tricyclic compounds, preparation methods, and their uses
07/11/2013US20130178486 Serine/threonine kinase inhibitors
07/11/2013US20130178478 Pyridazine amide compounds
07/11/2013US20130178475 sGC STIMULATORS
07/11/2013US20130178473 Compounds modulating c-fms and/or c-kit activity and uses therefor
07/11/2013US20130178472 Arylsulfonamide pyridine-pyridinone derivatives, preparation of same, and therapeutic use thereof
07/11/2013US20130178469 Novel antiviral agents
07/11/2013US20130178468 Hiv integrase inhibitors
07/11/2013US20130178462 Compounds for the reduction of beta-amyloid production
07/11/2013US20130178458 Substituted (1-(methylsulfonyl)azetidin-3-yl)(heterocycloalkyl)methanone analogs as antagonists of muscarinic acetylcholine m1 receptors
07/11/2013US20130178456 Arylethynyl derivatives
07/11/2013US20130177632 2,4,5-trisubstituted imidazoles and their use as anti-microbial agents
07/11/2013DE102012200360A1 Substituierte Triazine und ihre Verwendung Substituted triazines and their use
07/11/2013DE102012200354A1 New heteroaryl-substituted pyrazolopyridine compounds are soluble guanylate cyclase stimulators, useful to treat e.g. heart disease, angina pectoris, hypertension, pulmonary hypertension, ischemia, vascular disease or renal insufficiency
07/11/2013DE102012200349A1 Substituierte annellierte Pyrimidine und Triazine und ihre Verwendung Substituted fused pyrimidines and triazines and their use
07/10/2013EP2613375A1 Organic semiconductor particulate material, organic semiconductor thin-film, dispersion liquid for forming organic semiconductor film, method for producing organic semiconductor thin-film, and organic thin-film transistor
07/10/2013EP2612860A1 Quinazoline derivatives substituted by aniline, preparation method and use thereof
07/10/2013EP2612854A1 Aminothiazolidine and aminotetrahydrothiazepine derivatives as BACE 1 inhibitors
07/10/2013EP2611806A1 Deuterium-enriched heterocyclic compounds as kinase inhibitors
07/10/2013EP2611805A1 Fused triazoles for the treatment or prophylaxis of mild cognitive impairment
07/10/2013EP2611804A1 Novel compounds and compositions for the inhibition of nampt
07/10/2013EP2611803A1 Method for the production of 5-fluoro-1h-pyrazolo[3,4-b]pyridine-3-carbonitrile
07/10/2013EP2611802A1 Bicyclic aza heterocycles, and use thereof
07/10/2013EP2611801A1 Herbicidally active ketosultams and diketopyridines
07/10/2013EP2611777A1 4- { [ ( pyridin- 3 - yl -methyl) aminocarbonyl]amino} benzene - sulfone derivatives as nampt inhibitors for therapy of diseases such as cancer
07/10/2013EP2611776A2 Production method of intermediate compound for synthesizing medicament
07/10/2013EP2611446A1 Crystalline forms of maraviroc phosphate and process for maraviroc amorphous form
07/10/2013EP2611444A1 Heterocyclyl compounds as histamine h3 receptor ligands
07/10/2013CN103201273A Novel compounds for organic electronic material and organic electroluminescent device using the same
07/10/2013CN103201267A Ampk-activating heterocyclic compounds and methods for using the same
07/10/2013CN103201265A Novel microbiocides
07/10/2013CN103193777A Method for preparing zodi-perylene tetracarboxylic acid diimide derivative
07/10/2013CN103193776A Synthetic method of novel naphthyridine derivative with anti-tumor curative effect
07/10/2013CN103193775A Perylene imide derivative micron or nano wires and application thereof
07/10/2013CN103193774A Synthesis method of 4-chloro-pyrrolo-pyridine
1 ... 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 ... 646